2022
2021
2019
2018
←
1
2
3
4
→
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Nov 10, 2021
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M
Oct 22, 2021
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch
Oct 12, 2021
Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
Oct 4, 2021
Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market
Oct 1, 2021
Nutriband Inc.'s Abuse Deterrent Transdermal Technology Patent Granted by Japan's Patent Office
Apr 23, 2019
Nutriband Inc.'s Abuse Deterrent Transdermal Technology Patent Granted by European Patent Office
Mar 26, 2019
Nutriband Inc. Granted Prioritized Examination from the United States Patent and Trademark Office for Abuse Deterrent Technology Patent Application
Jan 29, 2019
Nutriband Inc. Issues Corrective Press Release on Initiation of Coverage
Nov 8, 2018
Small Cap Consumer Research Initiates Coverage of Nutriband Inc. in New Report
Nov 8, 2018